BANKANSEBANKA BIOLOO LIMITEDMediumNeutral
Announced Thu, 13 Aug · 20:59 IST

Banka BioLoo Q1 FY26-27 Investor Presentation: Revenue up 20.5%, PAT up 162%

Mgmt Guided Margin ImprovementOrder Pipeline DisclosedInvestor Communications View source PDFExplain this filing

BANKA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-4.9%1-day move
₹82.00
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-4.9+0.7-2.7-3.3-4.9
Up moveDown movePending
AI summary

Banka BioLoo filed its Q1 FY26-27 investor presentation. Revenue rose 20.5% YoY to Rs 16.4 Cr, EBITDA jumped 46.6% to Rs 1.51 Cr, and PAT surged 162.3% to Rs 37 lakh. Unexecuted order book stands at Rs 82 Cr, providing multi-quarter revenue visibility. Subsidiary Megaliter Varunaa now has 15 projects with 11.7 MLD capacity and Rs 122 Cr lifetime value. New client wins include Auro Infra, Brigade, Reliance and RMZ.

Likely market impact

Strong margin expansion and healthy order book visibility support growth outlook. Megaliter subsidiary adds long-term revenue visibility of Rs 122 Cr.